Amneal Pharmaceuticals (AMRX) Operating Expenses (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Operating Expenses of $182.4 million for Q1 2026, up 14.79% year-over-year from $158.9 million in Q1 2025, and down 0.74% quarter-over-quarter from $183.7 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Operating Expenses (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Operating Expenses history runs 10 years deep, the most recent figure standing at $182.4 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 14.79% year-over-year to $182.4 million; the TTM figure through Mar 2026 stood at $740.7 million (up 9.73% YoY), while the FY2025 annual figure was $717.2 million, up 7.13% from the prior year.
- Operating Expenses for Q1 2026 stood at $182.4 million, down from $183.7 million in the prior quarter.
- The five-year high for Operating Expenses was $201.3 million in Q3 2025, with the low at $141.3 million in Q1 2023.
- The 5-year median for Operating Expenses is $155.2 million (2023), against an average of $162.4 million.
- The sharpest annual moves came in 2022 and 2024: Operating Expenses dropped 8.28% in 2022, then rose 18.2% in 2024.
- Amneal Pharmaceuticals' Operating Expenses stood at $143.5 million in 2022, then gained by 8.19% to $155.2 million in 2023, then grew by 18.2% to $183.4 million in 2024, then increased by 0.16% to $183.7 million in 2025, then dropped by 0.74% to $182.4 million in 2026.
- Business Quant data shows AMRX's Operating Expenses at $182.4 million in Q1 2026, $183.7 million in Q4 2025, and $201.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 1.29 Bn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 215.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -2.85 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | 452.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 1.45 Bn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 807.50 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 550.00 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Amneal Pharmaceuticals | 5.71 Bn | 5.58 Bn | 334.51 Mn | 195.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 195.34 Mn |
| Mar 31, 2026 | 182.40 Mn |
| Dec 31, 2025 | 183.75 Mn |
| Sep 30, 2025 | 201.31 Mn |
| Jun 30, 2025 | 173.25 Mn |
| Mar 31, 2025 | 158.90 Mn |
| Dec 31, 2024 | 183.45 Mn |
| Sep 30, 2024 | 179.96 Mn |
| Jun 30, 2024 | 152.74 Mn |
| Mar 31, 2024 | 153.36 Mn |
| Dec 31, 2023 | 155.20 Mn |
| Sep 30, 2023 | 155.42 Mn |
| Jun 30, 2023 | 143.45 Mn |
| Mar 31, 2023 | 141.30 Mn |
| Dec 31, 2022 | 143.45 Mn |
| Sep 30, 2022 | 150.89 Mn |
| Jun 30, 2022 | 149.55 Mn |
| Mar 31, 2022 | 152.19 Mn |
| Dec 31, 2021 | 156.41 Mn |
| Sep 30, 2021 | 140.75 Mn |